Congratulations to george demetri for his amazing Karnofsky Memorial Award #ASCO20 . Feeling inspired by his scientific vision, determination, emphasis on collaboration, humility, and dedication to patients.

Decision tree in mRCC #ASCO20 OncoAlert

As #ASCO20 wraps up, taking a moment to thank the dedicated ⁦ASCO⁩ staff and ⁦Tatiana Prowell, MD⁩ et al who planned not 1 or 2 but THREE iterations of the annual meeting (original, virtual scientific, virtual educational). Hope you get to take a (non-virtual) vacation!

I joined Twitter two years ago during #ASCO20 . Since then, I have virtually met a lot of awesome people on this app! The past two years of this pandemic have been awful in many ways and very isolating. Grateful for the connections on here ❤️

#MyTwitterAnniversary

' #ASCO20 Virtual Ed Program in (almost) 400 Twitter profile pics ' Luca Dezzani
Thanks to everyone for your support, together we continue to produce and spread knowledge about cancer.
#ASCO20 #Cancer #OncoTeam

It is an honor to continue collaborating with Supriya Mohile Melissa (Kah Poh) Loh, MBBCh BAO, MS, FACCC Enrique Soto Paty Navarrete and everyone at INCMNSZ and Wilmot Cancer Institute to improve geriatric oncology care throughout the world! #ASCO20

PCR vs NGS for ctDNA #ASCO20 ⁦ASCO⁩ ⁦OncoAlert⁩ #sarcoma

Previously presented at #ASCO20 , biomarker data from KATHERINE now out on CCR. T-DM1 outperformed trastuzumab in all biomarker-defined subgroups, with a major benefit in HER2-⬆️ and PDL1-⬇️ tumors on residual dz- which fare poorly with trastuzumab alone.
aacrjournals.org/clincancerres/…

Here you go ! Two of my fav speakers H. Jack West, MD Joshua Bauml, MD in a debate on ADAURA trial presented at #ASCO20 hosted by Solange Peters
Thank you OncoViews

Liquid biopsy field is getting crowded ASCO #ASCO20 #sarcoma ⁦OncoAlert⁩

Next up, Dr Nakagawa presents data on trastuzumab deruxtecan in HER2 overexpressing NSCLC. Recall this agent showed remarkable activity in HER2 mutated NSCLC at #ASCO20 . Based on the MOA, I would have expected HER2 IHC to really identify patients likely to benefit #LCSM #WCLC20

This slides sums its all how 2020-21 is going to look like for #CART . Lots of options to choose but with many nuances ! Stephanie Farnia Navneet Majhail, MD, MS ASCO Tatiana Prowell, MD #ASCO20

Cell therapy is developing at an exponential rate, especially in hemato-oncology. Excellent news for our patients. Great overview of Navneet Majhail, MD, MS at #ASCO20

Dana-Farber's George D. Demetri, MD, FASCO (george demetri), shares remarks before he opens this weekend's ASCO virtual education program with the David A. Karnofsky Memorial Award and Lecture. Tune in at 8:30am ET for more #ASCO20

Another example where physicians underappreciate how toxicities impact patients -- when do #PROs become part of standard clinical practice?

#ASCO20 #supponc Arjun Gupta Tatiana Prowell, MD

At #ASCO20 educational session Dr Neal Shore presented the below figure, showing how the majority of pts in mCSPS are only getting ADT. Multiple studies now show OS benefit with intensifying ADT. I am hoping the final #TITAN results #GU21 will support a change in patient care

#ASCO20 ➡️ #ASCO23

This tweet from 2020 showed that OS was really important! And today, we heard it.

ASCO20 Virtual Scientific Program Research Round Up: Central Nervous System Tumors and Lymphoma #NonHodgkinLymphoma #BloodCancer #Leukemia #MultipleMyeloma [Video] ASCO: You’re listening to a podcast from Cancer.Net. This cancer information… dlvr.it/T6J13W

Taking a pause from covering #ASCO22 for MD Anderson Cancer Center to take in some social media insights from Don S. Dizon MD (he/him) 🇬🇺 and Merry-Jennifer Markham, MD, FACP, FASCO.

Look at that impression jump from #ASCO19 to #ASCO20 when the meeting turned virtual. Twitter was there to fill in those gaps!

Sunset #orangemoment this evening as #ASCO20 exemplary and complimentary educational sessions officially end!Good time to donate unused Chicago cab and Uber money fal.cn/UniteANDConquer - text ASCO to 41444